Back
Candel Therapeutics, Inc. Stock Predictions
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
50
CADL
Candel Therapeutics, Inc.
Last Price:
$5.34
Seasonality Move:
8.7%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCandel Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Candel Therapeutics, Inc. has on average historically risen by 93.9% based on the past 4 years of stock performance.
-
Candel Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Candel Therapeutics, Inc. Stock Undervalued?The current Candel Therapeutics, Inc. [CADL] share price is $5.26. The Score for CADL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CADL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Candel Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Candel Therapeutics, Inc. has on average historically risen by 93.9% based on the past 4 years of stock performance.
Candel Therapeutics, Inc. Stock Rating
Sell
50
Candel Therapeutics, Inc. (CADL)
is a Sell
Is Candel Therapeutics, Inc. overpriced?
-
Candel Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Candel Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
candeltx.com
52-Week Data
52-Week High:
14.60
52-Week Low:
4.25
Prediction Charts
Market Cap:
288.8M
Price in USD:
5.26
Volume:
1.4M
Beta:
-0.94
Technical Analysis
SMA50:
5.23
SMA100:
5.54
SMA200:
5.83
52-Wk Change:
18.74%
Stock Predictions
-
Is Candel Therapeutics, Inc. stock public?Yes, Candel Therapeutics, Inc. is a publicly traded company.
-
What is the Candel Therapeutics, Inc. stock quote today?The Candel Therapeutics, Inc. stock price is 5.26 USD today.
-
How to buy Candel Therapeutics, Inc. stock online?You can buy Candel Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 4.53 | 4.64 | 4.73 | 4.51 |
| Nov-17 | 4.64 | 4.73 | 4.98 | 4.57 |
| Nov-18 | 4.66 | 4.62 | 4.70 | 4.45 |
| Nov-19 | 4.60 | 4.42 | 4.72 | 4.40 |
| Nov-20 | 4.46 | 4.42 | 4.63 | 4.38 |
| Nov-21 | 4.44 | 4.55 | 4.67 | 4.37 |
| Nov-24 | 4.61 | 4.53 | 4.68 | 4.51 |
| Nov-25 | 4.57 | 4.47 | 4.57 | 4.35 |
| Nov-26 | 4.48 | 4.62 | 4.66 | 4.42 |
| Nov-28 | 4.65 | 4.77 | 4.87 | 4.63 |
| Dec-1 | 4.67 | 4.48 | 4.71 | 4.42 |
| Dec-2 | 4.52 | 4.42 | 4.54 | 4.38 |
| Dec-3 | 4.45 | 5.02 | 5.05 | 4.43 |
| Dec-4 | 5.00 | 5.26 | 5.32 | 4.97 |
Candel Therapeutics, Inc. Earnings
Candel Therapeutics, Inc. Earnings Report: Per Share Candel Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Candel Therapeutics, Inc. Forecast Revenue Growth
Candel Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Candel Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and a decrease next year of $0.09 per share.
* Candel Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.